This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Sept 2026 quarter: consolidated revenue up 2%, net profit up 20%, margins lower
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 1.5 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated (quarter ended 30 Sept 2026): revenue Rs 3,942.57 lakh versus Rs 3,864.75 lakh a year earlier, up 2%; net profit Rs 110.07 lakh versus Rs 91.37 lakh, up 20%. Profit before interest, depreciation and tax fell to 0.3% of sales from 2.3%. Standalone quarter revenue Rs 2,501.01 lakh and profit Rs 61.65 lakh. Half-year consolidated revenue Rs 5,660.97 lakh, profit Rs 214.25 lakh, operating cash flow negative Rs 235.90 lakh.
Profit growth was driven by other income, not trade; core margins narrowed and half-year operating cash flow was negative.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹39.43 Cr | ₹38.65 Cr | +2.0% |
| Operating profit | ₹0.11 Cr | ₹0.88 Cr | −87.3% |
| Profit after tax | ₹1.10 Cr | ₹0.91 Cr | +20.5% |
| EBITDA margin | 1.2% | 3.2% | −2.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.